Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic

Objectives: Early in the COVID-19 pandemic, people with underlying comorbidities were overrepresented in hospitalised cases of COVID-19, but the relationship between comorbidity and COVID-19 outcomes was complicated by potential confounding by age. This review therefore sought to characterise the in...

Full description

Bibliographic Details
Main Authors: Kate E. Mason, Gillian Maudsley, Philip McHale, Andy Pennington, Jennifer Day, Ben Barr
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2021.584182/full
_version_ 1819109293555712000
author Kate E. Mason
Gillian Maudsley
Philip McHale
Andy Pennington
Jennifer Day
Ben Barr
author_facet Kate E. Mason
Gillian Maudsley
Philip McHale
Andy Pennington
Jennifer Day
Ben Barr
author_sort Kate E. Mason
collection DOAJ
description Objectives: Early in the COVID-19 pandemic, people with underlying comorbidities were overrepresented in hospitalised cases of COVID-19, but the relationship between comorbidity and COVID-19 outcomes was complicated by potential confounding by age. This review therefore sought to characterise the international evidence base available in the early stages of the pandemic on the association between comorbidities and progression to severe disease, critical care, or death, after accounting for age, among hospitalised patients with COVID-19.Methods: We conducted a rapid, comprehensive review of the literature (to 14 May 2020), to assess the international evidence on the age-adjusted association between comorbidities and severe COVID-19 progression or death, among hospitalised COVID-19 patients – the only population for whom studies were available at that time.Results: After screening 1,100 studies, we identified 14 eligible for inclusion. Overall, evidence for obesity and cancer increasing risk of severe disease or death was most consistent. Most studies found that having at least one of obesity, diabetes mellitus, hypertension, heart disease, cancer, or chronic lung disease was significantly associated with worse outcomes following hospitalisation. Associations were more consistent for mortality than other outcomes. Increasing numbers of comorbidities and obesity both showed a dose-response relationship. Quality and reporting were suboptimal in these rapidly conducted studies, and there was a clear need for additional studies using population-based samples.Conclusions: This review summarises the most robust evidence on this topic that was available in the first few months of the pandemic. It was clear at this early stage that COVID-19 would go on to exacerbate existing health inequalities unless actions were taken to reduce pre-existing vulnerabilities and target control measures to protect groups with chronic health conditions.
first_indexed 2024-12-22T03:23:31Z
format Article
id doaj.art-b2b6e198e17b49bb84a4925229cc617e
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-12-22T03:23:31Z
publishDate 2021-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-b2b6e198e17b49bb84a4925229cc617e2022-12-21T18:40:40ZengFrontiers Media S.A.Frontiers in Public Health2296-25652021-08-01910.3389/fpubh.2021.584182584182Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the PandemicKate E. MasonGillian MaudsleyPhilip McHaleAndy PenningtonJennifer DayBen BarrObjectives: Early in the COVID-19 pandemic, people with underlying comorbidities were overrepresented in hospitalised cases of COVID-19, but the relationship between comorbidity and COVID-19 outcomes was complicated by potential confounding by age. This review therefore sought to characterise the international evidence base available in the early stages of the pandemic on the association between comorbidities and progression to severe disease, critical care, or death, after accounting for age, among hospitalised patients with COVID-19.Methods: We conducted a rapid, comprehensive review of the literature (to 14 May 2020), to assess the international evidence on the age-adjusted association between comorbidities and severe COVID-19 progression or death, among hospitalised COVID-19 patients – the only population for whom studies were available at that time.Results: After screening 1,100 studies, we identified 14 eligible for inclusion. Overall, evidence for obesity and cancer increasing risk of severe disease or death was most consistent. Most studies found that having at least one of obesity, diabetes mellitus, hypertension, heart disease, cancer, or chronic lung disease was significantly associated with worse outcomes following hospitalisation. Associations were more consistent for mortality than other outcomes. Increasing numbers of comorbidities and obesity both showed a dose-response relationship. Quality and reporting were suboptimal in these rapidly conducted studies, and there was a clear need for additional studies using population-based samples.Conclusions: This review summarises the most robust evidence on this topic that was available in the first few months of the pandemic. It was clear at this early stage that COVID-19 would go on to exacerbate existing health inequalities unless actions were taken to reduce pre-existing vulnerabilities and target control measures to protect groups with chronic health conditions.https://www.frontiersin.org/articles/10.3389/fpubh.2021.584182/fullCOVID-19coronaviruscomorbiditychronic diseasereview
spellingShingle Kate E. Mason
Gillian Maudsley
Philip McHale
Andy Pennington
Jennifer Day
Ben Barr
Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
Frontiers in Public Health
COVID-19
coronavirus
comorbidity
chronic disease
review
title Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
title_full Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
title_fullStr Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
title_full_unstemmed Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
title_short Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
title_sort age adjusted associations between comorbidity and outcomes of covid 19 a review of the evidence from the early stages of the pandemic
topic COVID-19
coronavirus
comorbidity
chronic disease
review
url https://www.frontiersin.org/articles/10.3389/fpubh.2021.584182/full
work_keys_str_mv AT kateemason ageadjustedassociationsbetweencomorbidityandoutcomesofcovid19areviewoftheevidencefromtheearlystagesofthepandemic
AT gillianmaudsley ageadjustedassociationsbetweencomorbidityandoutcomesofcovid19areviewoftheevidencefromtheearlystagesofthepandemic
AT philipmchale ageadjustedassociationsbetweencomorbidityandoutcomesofcovid19areviewoftheevidencefromtheearlystagesofthepandemic
AT andypennington ageadjustedassociationsbetweencomorbidityandoutcomesofcovid19areviewoftheevidencefromtheearlystagesofthepandemic
AT jenniferday ageadjustedassociationsbetweencomorbidityandoutcomesofcovid19areviewoftheevidencefromtheearlystagesofthepandemic
AT benbarr ageadjustedassociationsbetweencomorbidityandoutcomesofcovid19areviewoftheevidencefromtheearlystagesofthepandemic